North America Operating Room Equipment Market Revenue, Opportunity, Forecast and Value Chain 2021

North America Operating Room Equipment Market
Summary 
The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Click here for sample report  @ http://www.wiseguyreports.com/sample-request/522140-north-america-operating-room-equipment-market-outlook-to-2021
Scope of the Report
- Market size for Operating Room Equipment market segments - Operating Room Tables, Operating Room Lights and Surgical Booms.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Operating Room Equipment market.
- Global corporate-level profiles of key companies operating within the North America Operating Room Equipment market.
- Key players covered include Steris Corporation, Stryker Corporation, Skytron, LLC, Getinge AB and others.
  Table of Contents 
1 Table of Contents
1 Table of Contents 2
    1.1 List of Tables 5
    1.2 List of Figures 6
2 Introduction 8
    2.1 What Is This Report About? 8
    2.2 Operating Room Equipment Market Segmentation 8
    2.3 Definitions of Markets Covered in the Report 9
3 Operating Room Equipment Market, North America 10
    3.1 Operating Room Equipment Market, North America, Revenue ($m), 2007-2021 10
    3.2 Operating Room Equipment Market, North America, Category Comparison by Revenue ($m), 2007-2021 12
    3.3 Operating Room Equipment Market, North America, Revenue ($m), 2007-2014 14
    3.4 Operating Room Equipment Market, North America, Revenue ($m), 2014-2021 16
    3.5 Operating Room Equipment Market, North America, Volume (Units), 2007-2021 18
    3.6 Operating Room Equipment Market, North America, Volume (Units), 2007-2014 20
    3.7 Operating Room Equipment Market, North America, Volume (Units), 2014-2021 22
    3.8 Operating Room Equipment Market, North America, Company Share by Revenue ($m), 2014 24

  .Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/522140-north-america-operating-room-equipment-market-outlook-to-2021
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Real Estate Revenue, Opportunity, Forecast and Value Chain 2017

Real Estate

Summary 

Essential resource for top-line data and analysis covering the global real estate market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

The real estate industry looks at renting and leasing residential properties. The industry is valued using the total revenues generated by landlords via the leasing and renting of private and council properties. Values are calculated using the average annual rent multiplied by the number of rented properties. Volume includes number of houses/properties rented out (vacant properties excluded). Leading companies relate to companies that are involved in residential property rental and development business. Any currency conversions used in the creation of this report have been calculated using constant annual average 2016 exchange rates. 

Click here for sample report  @ http://www.wiseguyreports.com/sample-request/1473996-real-estate-global-industry-almanac-2017

Scope of the Report

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global real estate market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global real estate market
- Leading company profiles reveal details of key real estate market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global real estate market with five year forecasts by both value and volume

  Table of Contents 

Table of Contents
EXECUTIVE SUMMARY 2
Market value 2
Market value forecast 2
Market volume 2
Market volume forecast 2
Geography segmentation 2
Introduction 36
What is this report about? 36
Who is the target reader? 36
How to use this report 36
Definitions 36
Global Real Estate 37
Market Overview 37
Market Data 38
Market Segmentation 40
Market outlook 41
Five forces analysis 43
Real Estate in Asia-Pacific 52
Market Overview 52
Market Data 53     

  .Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1473996-real-estate-global-industry-almanac-2017

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Upcoming Tourism Destinations in SA - Granular Market Report and Review, 2017

Upcoming Tourism Destinations in SA
Summary 
There is clear potential for tourism in South America. Colombia has the most promising economy of all countries, with an average annual rate of 4% real GDP growth up to 2025. However, current economic conditions in certain countries such as Brazil (recession) and Argentina (hyperinflation) are adversely affecting outbound tourism and benefitting domestic tourism. Furthermore, weak exchange rates in the region make consumers price sensitive impacting outbound travel, particularly to the US and Europe. On the other hand, the weak exchange rate encouraged the growth of arrivals from the US and European countries such as Spain, France, and Germany to South American countries. International arrivals grew the most (23%) in Chile in 2016.
Click here for sample report  @ http://www.wiseguyreports.com/sample-request/1474154-upcoming-tourism-destinations-in-south-america-flows-spending-in-argentina-brazil
Scope of the Report
- Brazil, the number one country for natural attractions according to the World Economic Forum Tourism Competitiveness Report of 2017, has not reaped the benefits of its potential. Having realized this, the Ministry of Tourism in Brazil aims to take over and manage areas in the country which have the ‘high potential for the development of tourism’. The move is expected to boost inbound and domestic tourism. Nevertheless, in 2016, Brazil was the most visited country in South America with 6.6 million tourists, mainly driven by the Summer Olympics, which were held in Rio.
- Tourism is a priority sector for most South American countries. Chile identified tourism as a strategic sector and allotted US$100 million to develop tourism over 2015 to 2018. Argentina aims to create 3000 new jobs over the period 2016-2019 with the promotion of tourist destinations. These efforts are expected to support the growth of inbound tourism over the coming years
  Table of Contents 
Executive Summary
Introduction
Predicted future issues for the South American tourism industry
Key Economic Drivers
Argentina on growth track with recent reforms in place
Weak exchange rates adversely affecting South American outbound tourism
Peru’s tourism sector has the highest contribution to GDP in South America
Domestic Tourism
Chile ranks number one in terms of the percentage of income spent on domestic trips
Weak real encouraging Brazilians to prefer domestic trips over outbound
As outbound becomes more expensive due to strong dollar, domestic spending is forecast to grow
Inbound Tourism
Tourism risk assessment for South America
Brazil banking on tourism boost after 2016 Olympics   
  .Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1474154-upcoming-tourism-destinations-in-south-america-flows-spending-in-argentina-brazil
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

EU5 Glaucoma Surgery Devices Volume Forecast and Value Chain Analysis to 2022

EU5 Glaucoma Surgery Devices
Summary 
The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Click here for sample report  @ http://www.wiseguyreports.com/sample-request/826134-eu5-glaucoma-surgery-devices-market-outlook-to-2022
Scope of the Report
- Market size and company share data for Glaucoma Surgery Devices market segements - Canaloplasty Micro Catheters and Glaucoma Drainage Devices.
- Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for each of the market segements.
- Global corporate-level profiles of key companies operating within the EU5 Glaucoma Surgery Devices market.
- Key players covered include Alcon, Inc., Abbott Medical Optics, Inc., New World Medical, Incorporated, Ellex Medical Lasers Limited and Others.
  Table of Contents 
1 Table of Contents
1 Table of Contents 2
    1.1 List of Tables 5
    1.2 List of Figures 6
2 Introduction 7
    2.1 What Is This Report About? 7
    2.2 Glaucoma Surgery Devices Market Segmentation 7
    2.3 Definitions of Markets Covered in the Report 8
3 Glaucoma Surgery Devices Market, EU5 9
    3.1 Glaucoma Surgery Devices Market, EU5, Revenue ($m), 2008-2022 9
    3.2 Glaucoma Surgery Devices Market, EU5, Revenue ($m), 2008-2015 11
    3.3 Glaucoma Surgery Devices Market, EU5, Revenue ($m), 2015-2022 13
    3.4 Glaucoma Surgery Devices Market, EU5, Volume (Units), 2008-2022 15
    3.6 Glaucoma Surgery Devices Market, EU5, Volume (Units), 2008-2015 17
    3.6 Glaucoma Surgery Devices Market, EU5, Volume (Units), 2015-2022 19
    3.7 Glaucoma Surgery Devices Market, EU5, Company Share by Revenue ($m), 2015 21  
  .Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/826134-eu5-glaucoma-surgery-devices-market-outlook-to-2022
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Current and forthcoming Leukotriene A 4 Hydrolase size in terms of volume and value H1 2017

Leukotriene A 4 Hydrolase
Summary 
Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) pipeline Target constitutes close to 6 molecules. Out of which approximately 6 molecules are developed by Companies.The molecules developed by companies in Phase II, Preclinical and Discovery stages are 2, 3 and 1 respectively. Report covers products from therapy areas Cardiovascular, Respiratory, Dermatology and Hematological Disorders which include indications Pulmonary Arterial Hypertension, Acne Vulgaris, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Emphysema and Lymphedema.
The latest report Leukotriene A 4 Hydrolase - Pipeline Review, H1 2017, outlays comprehensive information on the Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) targeted therapeutics development with respective active and dormant or discontinued projects.
 @ http://www.wiseguyreports.com/sample-request/1473952-leukotriene-a-4-hydrolase-lta-4-hydrolase-or-leukotriene-a4-hydrolase
Scope of the Report
- The report provides a snapshot of the global therapeutic landscape for Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6)
- The report reviews Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  Table of Contents 
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Overview
Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Companies Involved in Therapeutics Development
Celtaxsys Inc 
  .Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1473952-leukotriene-a-4-hydrolase-lta-4-hydrolase-or-leukotriene-a4-hydrolase
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Prostate Specific Antigen Trends and Drivers Analysis 2017 To 2022

Prostate Specific Antigen
Summary 
Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) pipeline Target constitutes close to 12 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I, IND/CTA Filed and Preclinical stages are 1, 1, 2, 1 and 4 respectively. Similarly, the universities portfolio in Phase II stages comprises 3 molecules, respectively. Report covers products from therapy areas Oncology which include indications Prostate Cancer, Metastatic Hormone Refractory (Castration Resistant and Androgen-Independent) Prostate Cancer.
The latest report Prostate Specific Antigen - Pipeline Review, H1 2017, outlays comprehensive information on the Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) targeted therapeutics development with respective active and dormant or discontinued projects.
 @ http://www.wiseguyreports.com/sample-request/1473955-prostate-specific-antigen-gamma-seminoprotein-or-kallikrein-3-or-p-30
Scope of the Report
- The report provides a snapshot of the global therapeutic landscape for Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77)
- The report reviews Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

  Table of Contents 
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Overview
Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type   
  .Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1473955-prostate-specific-antigen-gamma-seminoprotein-or-kallikrein-3-or-p-30
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Global Granzyme B (C11 or CTLA 1) Trends, Regulations and Competitive Landscape Outlook To 2022

Granzyme B (C11 or CTLA 1)
Summary 
Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) - Granzyme B is a serine protease secreted by granules of cytotoxic lymphocytes (CTLs), natural killer cells (NK cells) and cytotoxic T cells. Granzyme B is crucial for the rapid induction of target cell death by apoptosis, induced by interaction with cytotoxic T cells. It activates the intracellular cascade of caspases finally resulting in the killing of the target cells. The molecules developed by companies in Preclinical and Discovery stages are 8 and 2 respectively. Report covers products from therapy areas Dermatology, Immunology, Cardiovascular, Metabolic Disorders, Central Nervous System, Oncology and Toxicology which include indications Diabetic Foot Ulcers, Aortic Aneurysm, Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE), Hypertrophic Scars, Keloids, Skin Ulcers, Wounds, Abdominal Aortic Aneurysms, Alopecia, Dermal Ulcers, Multiple Myeloma (Kahler Disease), Multiple Sclerosis, Radiodermatitis, Rheumatoid Arthritis and Systemic Sclerosis (Scleroderma).
Furthermore, this report also reviews key players involved in Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) targeted therapeutics development with respective active and dormant or discontinued projects.
@ http://www.wiseguyreports.com/sample-request/1473954-granzyme-b-c11-or-ctla-1-or-cathepsin-g-like-1
Scope of the Report
- The report provides a snapshot of the global therapeutic landscape for Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79)
- The report reviews Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  Table of Contents 
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) - Overview
Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or Human Lymphocyte Protein or SECT or T Cell Serine Protease 1-3E or GZMB or EC 3.4.21.79) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies      .Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1473954-granzyme-b-c11-or-ctla-1-or-cathepsin-g-like-1
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)